Investors Capital Advisory Services’s Rosetta Genomics Ltd. ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
VKH
Investors Capital Advisory Services's ROSG Position: Q2 2016 in Review
Investors Capital Advisory Services reduced its Rosetta Genomics Ltd. (ROSG) stake by 6.7% in Q2 2016, selling an estimated $940 and leaving 917 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #710.
Investors Capital Advisory Services first reported a position in ROSG in Q2 2015 and has held it in 5 quarters since. The position peaked at $70K in Q2 2015. 10 funds tracked by Wall St. Rank hold ROSG as of Q2 2016.
- Investors Capital Advisory Services held 917 shares of Rosetta Genomics Ltd. worth $12K as of Q2 2016.
- Investors Capital Advisory Services sold 66 Rosetta Genomics Ltd. shares in Q2 2016, an estimated $940.
- Rosetta Genomics Ltd. made up ﹤0.01% of Investors Capital Advisory Services's portfolio in Q2 2016, its #710 holding.
- Investors Capital Advisory Services first reported a position in Rosetta Genomics Ltd. in Q2 2015 and has held it in 5 quarters since.
- Investors Capital Advisory Services's Rosetta Genomics Ltd. position peaked at $70K in Q2 2015.
- 10 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2016.
Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.